rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic
CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ — rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/682,010, entitled “Microparticle Multiplexing” filed by its affiliate company, DNA Medicine Institute (DMI). This application covers the addition of a length scale to hydrogel microparticles. A Notice of Allowance is a written notification from USPTO that review of the patent application has completed and issuance of the patent is pending. rHEALTH expects the patent to be issued within two months.
“In combination with our US Patent 9,568,425 “Multicoded Analytical Nanostrips,” our technology for highly multiplexed diagnostic tests in small sample volumes now has even broader patent protection,” said Dr. Eugene Y. Chan, Founder and CEO. “The fundamental aspects of this patent enable our unique technology to measure many analytes in a given small volume of sample at home or in the clinic.”
rHEALTH is an innovative digital health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH’s innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.
About DNA Medicine Institute
rHEALTH’s affiliate, DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.
VP, Corporate & Business Development / Media Relations